Cargando…
Intraductal Papillary Mucinous Carcinoma Versus Conventional Pancreatic Ductal Adenocarcinoma: A Comprehensive Review of Clinical-Pathological Features, Outcomes, and Molecular Insights
Intraductal papillary mucinous neoplasms (IPMN) are common and one of the main precursor lesions of pancreatic ductal adenocarcinoma (PDAC). PDAC derived from an IPMN is called intraductal papillary mucinous carcinoma (IPMC) and defines a subgroup of patients with ill-defined specificities. As compa...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268881/ https://www.ncbi.nlm.nih.gov/pubmed/34201897 http://dx.doi.org/10.3390/ijms22136756 |
_version_ | 1783720454664486912 |
---|---|
author | Mas, Léo Lupinacci, Renato M. Cros, Jérôme Bachet, Jean-Baptiste Coulet, Florence Svrcek, Magali |
author_facet | Mas, Léo Lupinacci, Renato M. Cros, Jérôme Bachet, Jean-Baptiste Coulet, Florence Svrcek, Magali |
author_sort | Mas, Léo |
collection | PubMed |
description | Intraductal papillary mucinous neoplasms (IPMN) are common and one of the main precursor lesions of pancreatic ductal adenocarcinoma (PDAC). PDAC derived from an IPMN is called intraductal papillary mucinous carcinoma (IPMC) and defines a subgroup of patients with ill-defined specificities. As compared to conventional PDAC, IPMCs have been associated to clinical particularities and favorable pathological features, as well as debated outcomes. However, IPMNs and IPMCs include distinct subtypes of precursor (gastric, pancreato-biliary, intestinal) and invasive (tubular, colloid) lesions, also associated to specific characteristics. Notably, consistent data have shown intestinal IPMNs and associated colloid carcinomas, defining the “intestinal pathway”, to be associated with less aggressive features. Genomic specificities have also been uncovered, such as mutations of the GNAS gene, and recent data provide more insights into the mechanisms involved in IPMCs carcinogenesis. This review synthetizes available data on clinical-pathological features and outcomes associated with IPMCs and their subtypes. We also describe known genomic hallmarks of these lesions and summarize the latest data about molecular processes involved in IPMNs initiation and progression to IPMCs. Finally, potential implications for clinical practice and future research strategies are discussed. |
format | Online Article Text |
id | pubmed-8268881 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-82688812021-07-10 Intraductal Papillary Mucinous Carcinoma Versus Conventional Pancreatic Ductal Adenocarcinoma: A Comprehensive Review of Clinical-Pathological Features, Outcomes, and Molecular Insights Mas, Léo Lupinacci, Renato M. Cros, Jérôme Bachet, Jean-Baptiste Coulet, Florence Svrcek, Magali Int J Mol Sci Review Intraductal papillary mucinous neoplasms (IPMN) are common and one of the main precursor lesions of pancreatic ductal adenocarcinoma (PDAC). PDAC derived from an IPMN is called intraductal papillary mucinous carcinoma (IPMC) and defines a subgroup of patients with ill-defined specificities. As compared to conventional PDAC, IPMCs have been associated to clinical particularities and favorable pathological features, as well as debated outcomes. However, IPMNs and IPMCs include distinct subtypes of precursor (gastric, pancreato-biliary, intestinal) and invasive (tubular, colloid) lesions, also associated to specific characteristics. Notably, consistent data have shown intestinal IPMNs and associated colloid carcinomas, defining the “intestinal pathway”, to be associated with less aggressive features. Genomic specificities have also been uncovered, such as mutations of the GNAS gene, and recent data provide more insights into the mechanisms involved in IPMCs carcinogenesis. This review synthetizes available data on clinical-pathological features and outcomes associated with IPMCs and their subtypes. We also describe known genomic hallmarks of these lesions and summarize the latest data about molecular processes involved in IPMNs initiation and progression to IPMCs. Finally, potential implications for clinical practice and future research strategies are discussed. MDPI 2021-06-23 /pmc/articles/PMC8268881/ /pubmed/34201897 http://dx.doi.org/10.3390/ijms22136756 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Mas, Léo Lupinacci, Renato M. Cros, Jérôme Bachet, Jean-Baptiste Coulet, Florence Svrcek, Magali Intraductal Papillary Mucinous Carcinoma Versus Conventional Pancreatic Ductal Adenocarcinoma: A Comprehensive Review of Clinical-Pathological Features, Outcomes, and Molecular Insights |
title | Intraductal Papillary Mucinous Carcinoma Versus Conventional Pancreatic Ductal Adenocarcinoma: A Comprehensive Review of Clinical-Pathological Features, Outcomes, and Molecular Insights |
title_full | Intraductal Papillary Mucinous Carcinoma Versus Conventional Pancreatic Ductal Adenocarcinoma: A Comprehensive Review of Clinical-Pathological Features, Outcomes, and Molecular Insights |
title_fullStr | Intraductal Papillary Mucinous Carcinoma Versus Conventional Pancreatic Ductal Adenocarcinoma: A Comprehensive Review of Clinical-Pathological Features, Outcomes, and Molecular Insights |
title_full_unstemmed | Intraductal Papillary Mucinous Carcinoma Versus Conventional Pancreatic Ductal Adenocarcinoma: A Comprehensive Review of Clinical-Pathological Features, Outcomes, and Molecular Insights |
title_short | Intraductal Papillary Mucinous Carcinoma Versus Conventional Pancreatic Ductal Adenocarcinoma: A Comprehensive Review of Clinical-Pathological Features, Outcomes, and Molecular Insights |
title_sort | intraductal papillary mucinous carcinoma versus conventional pancreatic ductal adenocarcinoma: a comprehensive review of clinical-pathological features, outcomes, and molecular insights |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268881/ https://www.ncbi.nlm.nih.gov/pubmed/34201897 http://dx.doi.org/10.3390/ijms22136756 |
work_keys_str_mv | AT masleo intraductalpapillarymucinouscarcinomaversusconventionalpancreaticductaladenocarcinomaacomprehensivereviewofclinicalpathologicalfeaturesoutcomesandmolecularinsights AT lupinaccirenatom intraductalpapillarymucinouscarcinomaversusconventionalpancreaticductaladenocarcinomaacomprehensivereviewofclinicalpathologicalfeaturesoutcomesandmolecularinsights AT crosjerome intraductalpapillarymucinouscarcinomaversusconventionalpancreaticductaladenocarcinomaacomprehensivereviewofclinicalpathologicalfeaturesoutcomesandmolecularinsights AT bachetjeanbaptiste intraductalpapillarymucinouscarcinomaversusconventionalpancreaticductaladenocarcinomaacomprehensivereviewofclinicalpathologicalfeaturesoutcomesandmolecularinsights AT couletflorence intraductalpapillarymucinouscarcinomaversusconventionalpancreaticductaladenocarcinomaacomprehensivereviewofclinicalpathologicalfeaturesoutcomesandmolecularinsights AT svrcekmagali intraductalpapillarymucinouscarcinomaversusconventionalpancreaticductaladenocarcinomaacomprehensivereviewofclinicalpathologicalfeaturesoutcomesandmolecularinsights |